UVP is Now an Analytik Jena Company
News Apr 18, 2013
Analytik Jena AG, based in Jena, Germany has acquired all of the outstanding shares of Upland, California based UVP, LLC including its subsidiary, Ultra-Violet Products, Ltd., located in Cambridge UK.
UVP is a leading manufacturer of bioimaging systems for applications in proteomics, genomics, plant and animal sciences.
The company also manufactures ultraviolet products, light sources, and laboratory equipment such as hybridization ovens, transilluminators, crosslinkers and PCR hoods.
The acquisition of UVP, LLC allows Analytik Jena to strengthen its presence in the US market and expand its product portfolio.
"With the acquisition of UVP, we are significantly expanding our business activities in the Life Science unit and are laying an excellent basis for developing our successful business model in the USA and neighboring regions. Here, we are combining efficient sales structures, a well-coordinated product portfolio and broad technological expertise in the respective core segments. Further extensive synergies are to arise, especially in sales in Europe and Asia. With UVP, Analytik Jena also gains a production plant in the US dollar currency area." says Klaus Berka, CEO of Analytik Jena AG.
Analytik Jena is a provider of modern analytical technology, life science systems for bioanalytical applications, and high-end optical consumer products.
With the integration of UVP into Analytik Jena's Life Science business unit, numerous synergies are expected.
According to Leighton Smith, UVP’s President and CEO, “UVP has an opportunity to contribute significantly to the growth and profitability of Analytik Jena’s Life Science business unit. Our combined manufacturing expertise, portfolio of products and distribution channels open up new market opportunities, and begins an exciting new chapter in UVP’s history of providing innovative products and solutions to our customers.”
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Study Indicates 75% of Human Genome is Non-functionalNews
An evolutionary biologist at the University of Houston has published new calculations that indicate no more than 25 percent of the human genome is functional.READ MORE
Molecular Mechanism That Enable Neuronal Connections to Change With Development DiscoveredNews
Researchers from King's College London have discovered a molecular mechanism that enables neuronal connections to change through experience, thus fuelling learning and memory formation.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018
EMBO Workshop: Integrating Systems Biology: From Networks to Mechanisms to Models
Apr 15 - Apr 17, 2018